Grant: Catalyst Grant: HIV/AIDS Vaccine Discovery Research (Can HIV Vaccine Initiative)
Université Laval
$100,000.00
A new human cell experimental system for evaluating prototype HIV-1 vaccines
EF 2008-09
Résumé
The development of an effective vaccine against human immunodeficiency virus type-1 (HIV-1) has proven an enormous scientific challenge that is partly due to the lack of a suitable experimental cell system to investigate protective immune responses to HIV-1.
Previous studies have shown that secondary lymphoid organs constitute preferred anatomical sites for HIV-1 replication and propagation.
Given that secondary lymphoid organs are essential for the development of effective immune responses, we are proposing to test whether human lymphoid tissue cultured ex vivo could represent an appropriate experimental cell system to critically evaluate candidate HIV-1 vaccines.
Programme
Catalyst Grant: HIV/AIDS Vaccine Discovery Research (Can HIV Vaccine Initiative)
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
174611
Name
Tremblay Michel J
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
HIV Vaccine Discovery
Projecttitle
A new human cell experimental system for evaluating prototype HIV-1 vaccines
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Catalyst Grant: HIV/AIDS Vaccine Discovery Research (Can HIV Vaccine Initiative)
Keyworddelim
Hiv; Human Lymphoid Tissue; Vaccine
Abstract
The development of an effective vaccine against human immunodeficiency virus type-1 (HIV-1) has proven an enormous scientific challenge that is partly due to the lack of a suitable experimental cell system to investigate protective immune responses to HIV-1.
Previous studies have shown that secondary lymphoid organs constitute preferred anatomical sites for HIV-1 replication and propagation.
Given that secondary lymphoid organs are essential for the development of effective immune responses, we are proposing to test whether human lymphoid tissue cultured ex vivo could represent an appropriate experimental cell system to critically evaluate candidate HIV-1 vaccines.
Competitiondate
200811
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tremblay, Michel J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~